Gene · 10153
Papers2,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid Leukemia. | Acta Haematol | 2024 | 38035547 | PubTator, text mining | PubMed |
| Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears. | Blood Adv | 2024 | 37967385 | PubTator, text mining | PubMed |
| Discordance between ABC blood phenotype and genotype in a domestic short-haired cat. | J Vet Intern Med | 2024 | 37921544 | PubTator, text mining | PubMed |
| Application of methyl jasmonate to control chilling tolerance of postharvest fruit and vegetables: a meta-analysis and eliciting metabolism review. | Crit Rev Food Sci Nutr | 2024 | 37702765 | PubTator, text mining | PubMed |
| Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia. | Haematologica | 2024 | 37345475 | PubTator, text mining | PubMed |
| NUP98 rearrangements in AML: molecular mechanisms and clinical implications. | Onco (Basel) | 2023 | 42164049 | PubTator, text mining | PubMed |
| Metastasis and cancer associated fibroblasts: taking it up a NOTCH. | Front Cell Dev Biol | 2023 | 38269089 | PubTator, text mining | PubMed |
| Identification of mitophagy-related biomarkers in human osteoporosis based on a machine learning model. | Front Physiol | 2023 | 38260098 | PubTator, text mining | PubMed |
| NOC1 is a direct MYC target, and its protein interactome dissects its activity in controlling nucleolar function. | Front Cell Dev Biol | 2023 | 38213308 | PubTator, text mining | PubMed |
| Genome-Wide Identification of the CBF Gene Family and ICE Transcription Factors in Walnuts and Expression Profiles under Cold Conditions. | Int J Mol Sci | 2023 | 38203199 | PubTator, text mining | PubMed |
| Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells. | Cells | 2023 | 38201282 | PubTator, text mining | PubMed |
| Regulation of m6A Methylome in Cancer: Mechanisms, Implications, and Therapeutic Strategies. | Cells | 2023 | 38201270 | PubTator, text mining | PubMed |
| Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis. | Front Microbiol | 2023 | 38188582 | PubTator, text mining | PubMed |
| Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children-the Polish Pediatric Leukemia and Lymphoma Study Group experience. | Front Immunol | 2023 | 38187390 | PubTator, text mining | PubMed |
| Integrative analysis of physiology and genomics provides insights into freeze tolerance adaptations of Acacia koa along an elevational cline. | Physiol Plant | 2023 | 38148190 | PubTator, text mining | PubMed |
| The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. | Curr Oncol | 2023 | 38132393 | PubTator, text mining | PubMed |
| The Identification of Nuclear FMRP Isoform Iso6 Partners. | Cells | 2023 | 38132127 | PubTator, text mining | PubMed |
| Added value of molecular karyotype in childhood acute lymphoblastic leukemia. | Cancer Innov | 2023 | 38125768 | PubTator, text mining | PubMed |
| Assessment of 2022 European LeukemiaNet risk classification system in real-world cohort from China. | Cancer Med | 2023 | 38098254 | PubTator, text mining | PubMed |
| Room-Temperature Columnar Liquid Crystals from Twisted and Macrocyclic 9,9'-Bifluorenylidene Mesogen with Ambipolar Carrier Transport Properties. | ACS Mater Au | 2023 | 38089099 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10153/papers?page=9